RecruitingNot ApplicableNCT07521267

Nano Coated Orthodontic Miniscrews for en Mass Retraction of the Upper Arch

Evaluation of Silver-Hydroxyapatite Nano-coated Versus Uncoated Orthodontic Miniscrews for en Masse Retraction of the Upper Anterior Segment: A Randomized Clinical Trial


Sponsor

Al-Azhar University

Enrollment

14 participants

Start Date

May 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

study will be directed to evaluate silver-hydroxyapatite nano-coated versus uncoated orthodontic miniscrews for en masse retraction of the upper anterior segment.


Eligibility

Min Age: 14 YearsMax Age: 20 Years

Inclusion Criteria5

  • Class I orthodontic cases with bimaxillary protrusion of the anterior segment of the upper jaw that need at least extraction for orthodontic treatment.
  • Age 14-20 years.
  • Good oral hygiene with healthy periodontium.
  • Need for an absolute skeletal anchorage.
  • Systemically healthy patients.

Exclusion Criteria5

  • Patient with craniofacial anomalies (e.g, cleft lip and palate)
  • Presence of systemic diseases or syndromes affecting bone metabolism (e.g, osteoporosis, rickets)
  • Poor oral hygiene or uncooperative patients.
  • Extensive dental caries or untreated periodontal disease.
  • History of trauma or surgery affecting the maxilla or mandible.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESilver nanoparticles

Patients will receive silver-hydroxyapatite nanocoated titanium miniscrews.These miniscrews will be placed in the maxillary bone for en masse retractonof the upper anterior teeth.

DEVICEuncoated titanium miniscrews

Patients will receive conventional uncoated titanium miniscrews of the same dimensions and design as the intervention of the group1, but without nano-coating.


Locations(1)

Faculty of Dental Medicine (Boys), Al-Azhar University

Cairo, Cairo Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07521267


Related Trials